CIK 0001937993 · <br>Emerging growth company
Cadrenal Therapeutics, Inc.
Sign in to watch- Ticker
- CVKD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880860746
- Phone
- 904-300-0701
- Business address
- 822 A1A NORTH, SUITE 306, PONTE VEDRA, FL, 32082
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Regulation FD disclosure · Other events
- EFFECT Other Notice of Effectiveness
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- D Other Notice of Sales of Unregistered Securities
- 8-K Event Material agreement · Unregistered share sale · Shareholder rights changed
- 424B5 Offering Prospectus
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Other events
- 424B3 Offering Prospectus
- EFFECT Other Notice of Effectiveness
- D Other Notice of Sales of Unregistered Securities
- 4 Planned sale Chief Financial Officer sold 9,933 shares at $6.97 ($69,233)
- UPLOAD Other SEC-generated Letter
Page 3 of 14 · 277 filings